Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis

BACKGROUND: In breast cancer, ER/PgR, HER2, and Ki-67 are important biological markers for predicting prognosis and making effective treatment decisions. In addition, changes in markers due to relapse are also clinically experienced; however, the frequency and clinical significance are still not ful...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Reiki, Osako, Tomofumi, Okumura, Yasuhiro, Tashima, Rumiko, Toyozumi, Yasuo, Arima, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214885/
https://www.ncbi.nlm.nih.gov/pubmed/22004841
http://dx.doi.org/10.1186/1477-7819-9-131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214885/
https://www.ncbi.nlm.nih.gov/pubmed/22004841
http://dx.doi.org/10.1186/1477-7819-9-131

Ejemplares similares